A randomized, open-label, cross-over drug interaction study to evaluate the effects of desvenlafaxine (DVS SR) and paroxetine on the pharmacokinetics of desipramine in healthy subjects

Trial Profile

A randomized, open-label, cross-over drug interaction study to evaluate the effects of desvenlafaxine (DVS SR) and paroxetine on the pharmacokinetics of desipramine in healthy subjects

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2009

At a glance

  • Drugs Desipramine; Desvenlafaxine; Paroxetine
  • Indications Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders; Premenstrual dysphoric disorder; Social phobia; Vasomotor symptoms
  • Focus Pharmacogenomic; Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 09 Oct 2007 Status changed from recruiting to completed
    • 18 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top